Quarterly report pursuant to Section 13 or 15(d)

Subsequent Event (Additional Information) (Details)

v3.22.2.2
Subsequent Event (Additional Information) (Details) - Subsequent Event - Nanjing IASO Biotherapeutics Co., Ltd.
$ in Thousands
Oct. 07, 2022
USD ($)
Subsequent Event [Line Items]  
Upfront payment $ 2,500
Total milestone payments $ 162,000